Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionPsychostimulant that enhances the level of phosphatidylcholine in the brain
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard Indication Neurology (unspecified)
Indication DetailsTreat memory disorders and behavior related to stroke, head injury, chronic disease and degenerative brain disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today